Impact of primary aldosteronism on renal function in patients with type 2 diabetes.

ABSTRACT:

Aims/introduction

Renal dysfunction might quickly progress in patients with type 2 diabetes mellitus, when accompanied by hypertension. However, whether primary aldosteronism (PA), which autonomously over-secretes aldosterone, causes additional renal damage in patients with type 2 diabetes mellitus is unclear. We evaluated the impact of PA on renal function in patients with type 2 diabetes mellitus.

Materials and methods

A retrospective review of all patients with type 2 diabetes mellitus who visited Yokohama Rosai Hospital's (Yokohama Japan) outpatient department between April 2017 and March 2018 was carried out. Records of patients with PA who underwent PA treatment by adrenalectomy or mineralocorticoid receptor antagonists (PA group) and those without PA (non-PA group) we

SUBMITTER: Katsuragawa S 

PROVIDER: S-EPMC7858111 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature